Workshop of European task force on medication-related osteonecrosis of the jaw-Current challenges

Affiliations

¹ Department of Oral & Maxillofacial Surgery, Copenhagen University Hospital, Copenhagen, Denmark.
² Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
³ Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians University Munich, Münich, Germany.
⁴ UCL Eastman Dental Institute and NIHR UCLH Biomedical Research Centre, University College London, London, UK.
⁵ Department of Neuroscience-DNS, Regional Center for Prevention, Diagnosis and Treatment of Medication and Radiation-related Bone Diseases of the Head and Neck, University of Padova, Padova, Italy.
⁶ Clinic of Hospital Dentistry, National & Kapodistrian University of Athens, Athens, Greece.
⁷ Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
⁸ Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway.
⁹ Division for Head, Neck, and Reconstructive Surgery, Department of Otorhinolaryngology, Unit of Oral and Maxillofacial Surgery, Oslo University Hospital, Oslo, Norway.
¹⁰ Department of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.

Free article

Morten Schiodt et al. Oral Dis. 2019 Oct.

Free article

. 2019 Oct;25(7):1815-1821.

doi: 10.1111/odi.13160. Epub 2019 Aug 19.

¹ Department of Oral & Maxillofacial Surgery, Copenhagen University Hospital, Copenhagen, Denmark.
² Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
³ Department of Oral and Maxillofacial Surgery, Ludwig-Maximilians University Munich, Münich, Germany.
⁴ UCL Eastman Dental Institute and NIHR UCLH Biomedical Research Centre, University College London, London, UK.
⁵ Department of Neuroscience-DNS, Regional Center for Prevention, Diagnosis and Treatment of Medication and Radiation-related Bone Diseases of the Head and Neck, University of Padova, Padova, Italy.
⁶ Clinic of Hospital Dentistry, National & Kapodistrian University of Athens, Athens, Greece.
⁷ Diagnostic and Interventional Radiology, University Hospital Zurich, Zurich, Switzerland.
⁸ Department of Oral Surgery and Oral Medicine, Faculty of Dentistry, University of Oslo, Oslo, Norway.
⁹ Division for Head, Neck, and Reconstructive Surgery, Department of Otorhinolaryngology, Unit of Oral and Maxillofacial Surgery, Oslo University Hospital, Oslo, Norway.
¹⁰ Department of Oral and Maxillofacial Surgery, University of Heidelberg, Heidelberg, Germany.

No abstract available

References

1. Abt, E. (2017). The risk of medication-related osteonecrosis of the jaw after dental extraction is higher for patients on intravenous as compared with oral antiresorptive drugs. Journal of Evidence Based Dental Practice, 17(2), 105-106. https://doi.org/10.1016/j.jebdp.2017.03.007
1. Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws AAOMS (2007). American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. Journal of Oral and Maxillofacial Surgery, 65(3), 369-376. https://doi.org/10.1016/j.joms.2006.11.003
1. Aljohani, S., Troeltzsch, M., Hafner, S., Kaeppler, G., Mast, G., & Otto, S. (2019). Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series. Oral Diseases, 25(2), 497-507. https://doi.org/10.1111/odi.12992
1. Ascani, G., Campisi, G., & Junquera Gutierrez, L. M. (2014). Current controversies in classification, management, and prevention of bisphosphonate-related osteonecrosis of the jaw. International Journal of Dentistry, 2014, 565743. https://doi.org/10.1155/2014/565743
1. Barasch, A., Cunha-Cruz, J., Curro, F. A., Hujoel, P., Sung, A. H., Vena, D.…Group, C. C (2011). Risk factors for osteonecrosis of the jaws: A case-control study from the CONDOR dental PBRN. Journal of Dental Research, 90(4), 439-444. https://doi.org/10.1177/0022034510397196